サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467894

腫瘍情報システム市場レポート：製品・サービス、用途、エンドユーザー、地域別、2024～2032年

Oncology Information Systems Market Report by Product and Services, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
腫瘍情報システム市場レポート：製品・サービス、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の腫瘍情報システム市場規模は2023年に40億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに69億米ドルに達し、2024～2032年の成長率（CAGR）は6.26%になると予測しています。

腫瘍情報システム（OIS）とは、がんの診断、患者プロファイルの最適化、生存率向上のための適切な治療法の特定を目的とした包括的な情報・画像管理ソリューションのことです。OISには、スクリーニング、予防、分析、治療、緩和ケアなどが含まれます。従来の技術と比較して、腫瘍学システムは遠隔アクセス、計画的治療、将来予測、臨床と非臨床取得データの適切な管理を記載しています。これとは別に、OISは診断の詳細や治療パターンの追跡を支援するため、クリニック、研究所、病院、研究センターで広く採用されています。

腫瘍情報システムの市場動向：

腫瘍情報システム市場は、タバコをベースとする製品の消費量の増加やライフスタイルの進化により、特に増加する高齢者人口の間で、がんの有病率が増加していることが主要要因となっています。OISは電子カルテ（EHR）を管理し、患者ベースのサービスの向上、疾病メカニズムに関する新たな洞察の創出、疾病の早期発見のほか、より良い治療選択肢の提供に役立っています。これに伴い、紙ベースの記録作成、処方、治療計画の誤りを軽減するためのブロックチェーンや人工知能（AI）の統合など、著しい技術的進歩が別の成長促進要因として作用しています。さらに、各国政府は研究開発（R&D）部門に大規模な資金を投入して遠隔腫瘍情報システムを導入しており、医療従事者は患者と物理的に同席することなく、モバイル・アプリケーションを通じてがんの長期モニタリングを行うことができます。その結果、特にコロナウイルス感染症（COVID-19）が発生し、それに伴う強制閉鎖が実施された際に、医療部門全体への導入が強化されました。その他にも、がんモニタリングシステムの利用可能性に関する消費者の意識の高まりや、免疫療法や放射線療法を実施するためのOISの導入が拡大していることなどが、市場に明るい展望をもたらしています。

本レポートで扱う主要質問

  • 2023年の腫瘍情報システムの世界市場規模は？
  • 2024～2032年にかけての世界の腫瘍情報システム市場の予想成長率は？
  • 腫瘍情報システムの世界市場を牽引する主要因は何か？
  • COVID-19が腫瘍情報システムの世界市場に与えた影響は？
  • 腫瘍情報システムの世界市場における製品・サービス別の区分は？
  • 腫瘍情報システムの世界市場の用途別区分は？
  • 腫瘍情報システムの世界市場のエンドユーザー別区分は？
  • 腫瘍情報システムの世界市場における主要地域は？
  • 腫瘍情報システムの世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の腫瘍情報システム市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品・サービス別

  • ソフトウェア
    • 市場動向
    • 主要セグメント
      • 患者情報システム
      • 治療計画システム
    • 市場予測
  • サービス
    • 市場動向
    • 主要セグメント
      • コンサルティングサービス
      • 実装サービス
      • 保守サービス
    • 市場予測

第7章 市場内訳：用途別

  • 放射線腫瘍
  • メディカル腫瘍
  • 外科腫瘍学

第8章 市場内訳：エンドユーザー別

  • 病院、画像診断センター
  • アブレーションケアセンター、がん治療センター
  • 政府機関
  • 研究機関

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Accuray Incorporated
    • Advanced Data Systems
    • Cerner Corporation（Oracle Corporation）
    • CureMD Healthcare
    • Elekta
    • EndoSoft LLC（Utech Products Inc.）
    • F. Hoffmann-La Roche Ltd
    • Koninklijke Philips N.V.
    • McKesson Corporation
    • OPTUM Inc.（United Healthcare Services Inc.）
    • RaySearch Laboratories
    • Varian Medical Systems Inc
図表

List of Figures

  • Figure 1: Global: Oncology Information Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Information Systems Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Oncology Information Systems Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Oncology Information Systems Market: Breakup by Product and Services (in %), 2023
  • Figure 5: Global: Oncology Information Systems Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Oncology Information Systems Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Oncology Information Systems Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Oncology Information Systems (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Oncology Information Systems (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Oncology Information Systems (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Oncology Information Systems (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Oncology Information Systems (Radiation Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Oncology Information Systems (Radiation Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Oncology Information Systems (Medical Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Oncology Information Systems (Medical Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Oncology Information Systems (Surgical Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Oncology Information Systems (Surgical Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Oncology Information Systems (Hospitals and Diagnostic Imaging Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Oncology Information Systems (Hospitals and Diagnostic Imaging Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Oncology Information Systems (Ablation Care Centers and Cancer Care Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Oncology Information Systems (Ablation Care Centers and Cancer Care Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Oncology Information Systems (Government Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Oncology Information Systems (Government Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Oncology Information Systems (Research Facilities) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Oncology Information Systems (Research Facilities) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Oncology Information Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Oncology Information Systems Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Oncology Information Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Oncology Information Systems Industry: SWOT Analysis
  • Figure 76: Global: Oncology Information Systems Industry: Value Chain Analysis
  • Figure 77: Global: Oncology Information Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Information Systems Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Oncology Information Systems Market Forecast: Breakup by Product and Services (in Million US$), 2024-2032
  • Table 3: Global: Oncology Information Systems Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Oncology Information Systems Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Oncology Information Systems Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Oncology Information Systems Market: Competitive Structure
  • Table 7: Global: Oncology Information Systems Market: Key Players
目次
Product Code: SR112024A5898

The global oncology information systems market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.26% during 2024-2032.

Oncology information systems (OIS) refers to a comprehensive information and image management solution that is designed for diagnosing, optimizing patient profile, and identifying suitable therapy for cancer to improve survival rate. They involve screening, prevention, analysis, treatment, and palliative care. As compared to conventional techniques, oncology systems offer remote access, planned treatment, future prediction, and proper management of clinical and non-clinical acquired data. Apart from this, OIS assists in keeping track of diagnostic details and treatment patterns, on account of which they are extensively employed in clinics, laboratories, hospitals, and research centers.

Oncology Information Systems Market Trends:

The oncology information systems market is majorly being driven by the increasing prevalence of cancer, especially amongst the rising geriatric population, due to the rising consumption of tobacco-based products and evolving lifestyles. OIS maintains electronic health records (EHR), which further assists in improving patient-based services, generating new insights into disease mechanism, detecting the early spread of the disease, and providing better treatment options. In line with this, significant technological advancements, such as the integration of blockchain and artificial intelligence (AI) to mitigate the errors of paper-based record creation, prescriptions, and treatment plans, is acting as another growth-inducing factor. Additionally, governments of various countries are extensively funding in the research and development (R&D) departments to introduce remote oncology information systems, which enables healthcare practitioners to perform long-term monitoring of cancer through mobile applications, without being physically present with the patient. This, in turn, has intensified their adoption across the healthcare sector, particularly during the ongoing coronavirus disease (COVID-19) and the consequent implementation of mandatory lockdowns. Other factors, such as growing consumer awareness regarding the availability of cancer monitoring systems and the escalating uptake of OIS to perform immunotherapy and radiation therapy, are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology information systems market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and services, application and end user.

Breakup by Product and Services:

Software

Patient Information Systems

Treatment Planning Systems

Services

Consulting Services

Implementation Services

Maintenance Services

Breakup by Application:

Radiation Oncology

Medical Oncology

Surgical Oncology

Breakup by End User:

Hospitals and Diagnostic Imaging Centers

Ablation Care Centers and Cancer Care Centers

Government Institutions

Research Facilities

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accuray Incorporated, Advanced Data Systems, Cerner Corporation (Oracle Corporation), CureMD Healthcare, Elekta, EndoSoft LLC (Utech Products Inc.), F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., McKesson Corporation, OPTUM Inc. (United Healthcare Services Inc.), RaySearch Laboratories and Varian Medical Systems Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global oncology information systems market in 2023?
  • 2. What is the expected growth rate of the global oncology information systems market during 2024-2032?
  • 3. What are the key factors driving the global oncology information systems market?
  • 4. What has been the impact of COVID-19 on the global oncology information systems market?
  • 5. What is the breakup of the global oncology information systems market based on the product and services?
  • 6. What is the breakup of the global oncology information systems market based on the application?
  • 7. What is the breakup of the global oncology information systems market based on the end user?
  • 8. What are the key regions in the global oncology information systems market?
  • 9. Who are the key players/companies in the global oncology information systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oncology Information Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Services

  • 6.1 Software
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Patient Information Systems
      • 6.1.2.2 Treatment Planning Systems
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Consulting Services
      • 6.2.2.2 Implementation Services
      • 6.2.2.3 Maintenance Services
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Radiation Oncology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Medical Oncology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Surgical Oncology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Diagnostic Imaging Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ablation Care Centers and Cancer Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Government Institutions
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Research Facilities
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accuray Incorporated
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Advanced Data Systems
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cerner Corporation (Oracle Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 CureMD Healthcare
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Elekta
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 EndoSoft LLC (Utech Products Inc.)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Koninklijke Philips N.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 McKesson Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 OPTUM Inc. (United Healthcare Services Inc.)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 RaySearch Laboratories
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Varian Medical Systems Inc
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio